Croda commits to Science Based Targets for reduction of greenhouse gas emissions

Group aiming to achieve a 50% reduction in absolute GHG emissions based on 2006 levels by 2030 and an 80% reduction by 2050.
Croda International has announced its commitment to reduce its greenhouse gas emissions in line with the Science Based Targets initiative.
Croda is one of the few companies within the speciality chemicals sector to commit to Science Based Targets (SBT), with the aim of restricting global warming to 1.5 °C above the pre-industrial average. With reductions in greenhouse gas emissions (GHG) a priority, Croda has already established Group targets to achieve a 50% reduction in absolute GHG emissions based on 2006 levels by 2030 and an 80% reduction by 2050.
With more than 60% of the company’s raw materials already coming from bio-based sources, Croda believes that that they are well positioned to not only reduce their GHG emissions, but to become ‘Climate Positive’. This ambitious target will focus on the use of more bio-based raw materials, and also through the ongoing work that Croda is undertaking to quantify the carbon savings derived from their products as they are used by their customers and the end consumers. In 2018, over 700,000 tonnes of GHG emissions were avoided through just four of Croda’s products in application. For example, Croda’s Coltide RadianceTM extends the lifetime of clothes, avoiding additional carbon and water intensive manufacture.
Terry Thistlethwaite, Vice President of Sustainability at Croda said: “We are proud to be one of around 600 companies taking science-based climate action and reducing greenhouse gas emissions by committing to Science Based Targets.
"Our business purpose is to use Smart Science to Improve Lives; this is just one area where we are pushing ourselves and supporting our customers to have a positive impact on the planet and society. We will continue to lead the speciality chemicals industry with our approach to sustainability.”
The Science Based Targets initiative is a collaboration between CDP, the United Nations Global Compact, World Resources Institute (WRI) and the World Wide Fund for Nature (WWF). It signals an acceleration in the transition to a low carbon economy and supports companies who are already demonstrating they have the skills, expertise and ingenuity to make this a reality.

Related News
-
News 3 ways ChatGPT will impact pharma marketing teams
What does the rise of AI-powered chatbots such as ChatGPT and GPT-4 mean for pharma marketeers? -
News Eli Lilly, Novo Nordisk, and Sanofi cut insulin prices by up to 78%
Insulin prices have dropped in a stark play by the three biggest makers of the product, after calls from the top of the US government. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Open letter challenges EU Commission on medicine supply chain
In an open letter to the European Commission, Medicines for Europe calls for a new medicine security contract with their goal to improve access to medicine and ensure a secure supply chain to Europe. -
News The Biggest Drug Approvals of 2022
A carefully curated list of the most notable drug approvals of the past year, covering neurology, oncology, and COVID-19, as well as a look at the most promising drugs up for review in 2023. -
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance